title: [Research progress on strain improvement of Acremonium chrysogenum by genetic engineering].
abstract: Acremonium chrysogenum, cephalosporin C (CPC) producing strain, is an important industrial microorganism. CPC is used to produce 7-ACA, a major intermediate for manufacturing of many first-line anti-infectious cephalosporin-antibiotics. The fermentation level of CPC determines the production, quality and cost of its downstream products. Therefore, it is necessary to develop the strains of A. chrysogenum. Along with the development of molecular biology, genetic manipulation technique is becoming more and more important in the field of molecular breeding. This paper reviews the latest research progresses on CPC biosynthesis and its regulation. Genetic manipulations of A. chrysogenum were summarized and concluded. We suggested that strain improvement of A. chrysogenum by means of induction and expression of biosynthetic and regulatory genes, as well as exogenous genes, and further optimization could be applied to different aspects including CPC production enhancement and metabolic pathway elongation, etc. Future direction of this field is also proposed. We believed that incorporation of comparative proteomics and genomic shuffling with molecular breeding could lead the achievements close to industry promptly.
authors: Shanghai Institute of Pharmaceutical Industry, Shanghai, China. huyj@sipi.com.cn
authors: You-Jia
authors: YJ
authors: Hu
authors: Bao-Quan
authors: BQ
authors: Zhu
mesh_terms: D000164:Acremonium / Q000235:genetics* / Q000378:metabolism; D002511:Cephalosporins / Q000096:biosynthesis*; D005818:Genetic Engineering
chemical_list: D002511:Cephalosporins; C025163:cephalosporin C